Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

115
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
115
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.8K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

177
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
177
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

1.0K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.0K
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

113
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
113
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atrial Substrate Progression in AF Patients: Insights From Unipolar Mapping.

Pacing and clinical electrophysiology : PACE·2026
Same author

Association between genetically predicted dietary patterns and atrial fibrillation: a two sample Mendelian randomization study.

European journal of nutrition·2026
Same author

Distinct Automaticity and Excitability Between Radiofrequency and Cryoballoon Ablation in Paroxysmal Atrial Fibrillation.

Pacing and clinical electrophysiology : PACE·2026
Same author

The prevalence, distribution and ablation of non-pulmonary vein triggers in older patients with paroxysmal atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Electrophysiological Characteristics of Coronary Sinus Activation Sequence Alteration During Left Lateral AP Ablation.

Pacing and clinical electrophysiology : PACE·2025
Same author

Impact of Different Pacing Sites on Pre-Implantation Screening Test of Subcutaneous Implantable Cardioverter Defibrillators.

Journal of cardiovascular electrophysiology·2025

Related Experiment Video

Updated: Sep 20, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.5K

Low Voltage Area Modification in Older Patients With Atrial Fibrillation.

Ning Chen1, Zhou Xu1, Hongwu Chen1

  • 1The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

Pacing and Clinical Electrophysiology : PACE
|May 23, 2025
PubMed
Summary

In older adults with atrial fibrillation (AF), low voltage areas (LVA) predict recurrence. Modifying LVA after pulmonary vein isolation significantly reduces AF recurrence in both paroxysmal AF (PAF) and persistent AF (PeAF) patients.

Keywords:
atrial fibrillation typeatrial tachyarrhythmiascircumferential pulmonary vein isolationlow voltage areaolder patients

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K

Related Experiment Videos

Last Updated: Sep 20, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.5K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

1.8K

Area of Science:

  • Cardiology
  • Electrophysiology
  • Geriatric Medicine

Background:

  • Age is a significant factor influencing low voltage areas (LVA) in atrial fibrillation (AF) patients.
  • Understanding LVA's role in older AF patients is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate the benefits of LVA modification in older patients (≥65 years) with AF.
  • To compare the efficacy of LVA modification in paroxysmal AF (PAF) versus persistent AF (PeAF).

Main Methods:

  • Sub-analysis of STABLE-SR-II and STABLE-SR-III trials.
  • Patients with PAF or PeAF underwent either CPVI alone or CPVI with additional LVA modification.
  • Primary outcome was freedom from atrial tachyarrhythmias (ATAs).

Main Results:

  • Analysis included 510 older patients (mean age 70.2 years).
  • Without LVA, ATAs recurrence risk was similar between PeAF and PAF.
  • Additional LVA modification significantly reduced ATAs recurrence in both PeAF (HR 0.35) and PAF (HR 0.41) patients.

Conclusions:

  • In older AF patients without LVA, PAF and PeAF have comparable recurrence rates post-CPVI.
  • LVA presence is linked to higher recurrence rates in both AF types.
  • LVA modification effectively lowers recurrence rates, regardless of AF type in older individuals.